Evidence map›Paper›PMID 40437575›Full record

ArticleBMC biology2025

p53-mediated suppression of the SLC7 A11/GPX4 signaling pathway promotes trophoblast ferroptosis in preeclampsia.

Tingting Liao, Xia Xu, Guiying Wang, Jianying Yan

Abstract read
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Ferroptosis-Mediated Placental Dysfunction in the Pathophysiology of Gestational Diabetes Mellitus.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  2. [Role of programmed cell death in platinum resistance in ovarian cancer].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tingting Liao *College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fujian Clinical Research Center for Maternal-Fetal Medicine, Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, National Key Obstetric Clinical Specialty Construction Institution of China, No. 18, Daoshan Road, Gulou District, Fuzhou, Fujian Province, China.
Xia Xu *College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fujian Clinical Research Center for Maternal-Fetal Medicine, Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, National Key Obstetric Clinical Specialty Construction Institution of China, No. 18, Daoshan Road, Gulou District, Fuzhou, Fujian Province, China.
Guiying WangCollege of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fujian Clinical Research Center for Maternal-Fetal Medicine, Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, National Key Obstetric Clinical Specialty Construction Institution of China, No. 18, Daoshan Road, Gulou District, Fuzhou, Fujian Province, China.
Jianying YanCollege of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fujian Clinical Research Center for Maternal-Fetal Medicine, Laboratory of Maternal-Fetal Medicine, Fujian Maternity and Child Health Hospital, National Key Obstetric Clinical Specialty Construction Institution of China, No. 18, Daoshan Road, Gulou District, Fuzhou, Fujian Province, China. yanjy2019@fjmu.edu.cn.

Funding

Fujian Provincial Health Technology Project 2024ZD01005Fujian Provincial Natural Science Foundation of China 2024Y0035Joint Funds for the Innovation of Science and Technology, Fujian Province 2020Y9134National Key Clinical Specialty Construction Program of China ObstetricStartup Fund for Scientific Research, Fujian Medical University 2023QH2046
6 · The paper itself

Abstract

backgroundFerroptosis is an iron-dependent form of non-apoptotic cell death that occurs through increased plasma membrane phospholipid peroxidation in the context of impaired plasma membrane phospholipid peroxide repair systems. It has been reported that p53 can inhibit the expression of cysteine/glutamate reverse transporter solute carrier family 7, member 11 (SLC7A11), a key component of system Xc-, thus inhibiting cysteine uptake and promoting reactive oxygen species (ROS) accumulation as an important part of cell ferroptosis. Preeclampsia (PE) is an idiopathic hypertensive disease of pregnancy. Spiral artery insufficiency and impaired placental development are present at all stages, leading to placental hypoperfusion, ischemia, and hypoxia. However, the role of ferroptosis, particularly p53-mediated trophoblast ferroptosis, in placental dysfunction during PE remains unclear.

resultsIn PE placental tissues, malondialdehyde (MDA) and total iron levels were elevated, and trophoblasts exhibited typical ferroptosis-associated morphological changes. Additionally, p53 mRNA and protein expression and the percentage of p53-positive cells were increased, while SLC7A11 and GPX4 mRNA and protein expression and the percentage of positive cells were decreased. VEGFR1 protein expression was upregulated, whereas VEGFA and PLGF protein expression was downregulated. p53 protein expression was negatively correlated with the expression of proteins in the SLC7A11/GPX4 signaling pathway, VEGFA, and PLGF. Conversely, there was a positive correlation between p53 expression and MDA, total iron concentration, and VEGFR1. In vitro, the ferroptosis inducer erastin increased ROS levels in trophoblast cells. The ferroptosis inhibitor Fer-1, the apoptosis inhibitor Z-VAD-FMK, and the necrosis inhibitor Nec-1 failed to prevent erastin-induced ROS elevation. In p53 + / + trophoblasts, erastin-induced ROS elevation was more pronounced than that in p53 - / - and control cells, and angiogenesis was impaired. In pregnant rats, p53 + / + placentas exhibited increased MDA and total iron levels, ferroptosis-like morphological changes in trophoblasts, and reduced CD34 expression. p53 protein expression was negatively correlated with CD34 expression.

conclusionThis study confirmed that trophoblast ferroptosis occurs in the pathological state of PE and that trophoblast are specifically sensitive to ferroptosis. p53 can mediate the SLC7A11/GPX4 signaling pathway to promote ferroptosis of trophoblast cells in the pathogenesis of PE. It is also speculated that increased p53 reactivity may mediate impaired angiogenesis in placental tissues.

Indexed as

Amino Acid Transport System y+FerroptosisPhospholipid Hydroperoxide Glutathione PeroxidasePre-EclampsiaSignal TransductionTrophoblastsTumor Suppressor Protein p53AnimalsFemaleHumansPlacentaPregnancyRatsRats, Sprague-DawleyAmino Acid Transport System y+glutathione peroxidase 4, ratPhospholipid Hydroperoxide Glutathione PeroxidaseSLC7A11 protein, humanTumor Suppressor Protein p53FerroptosisP53PreeclampsiaSLC7 A11/GPX4

Identifiers

PMID40437575
PMCPMC12121027

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.